Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ames

Showing results (141-150 of 335) with videos related to

Pageof 34
Sort By:
Scientific Reports|October 27, 2017
A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohortSteve Pedrini, Veer B Gupta, Eugene Hone, et al.
Gene|February 9, 2025
Identification of blood eQTLs in older adultsAbdulsalam Toyin, Karen A Mather, Nicola J Armstrong, et al.
BMC Geriatrics|September 15, 2017
A randomized controlled trial of physical activity with individual goal-setting and volunteer mentors to overcome sedentary lifestyle in older adults at risk of cognitive decline: the INDIGO trial protocolKay L Cox, Elizabeth V Cyarto, Christopher Etherton-Beer, et al.
Plos One|December 17, 2014
Genetics of microstructure of the corpus callosum in older adultsSri C Kanchibhotla, Karen A Mather, Anbupalam Thalamuthu, et al.
Journal of Clinical and Experimental Neuropsychology|January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
JAMA Neurology|May 29, 2013
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer diseaseVincent Doré, Victor L Villemagne, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|May 26, 2012
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal studyNicolas Villain, Gaël Chételat, Blandine Grassiot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Pageof 34

Showing results (141-150 of 335) with videos related to

Sort By:
Pageof 34
Scientific Reports|October 27, 2017
A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohortSteve Pedrini, Veer B Gupta, Eugene Hone, et al.
Gene|February 9, 2025
Identification of blood eQTLs in older adultsAbdulsalam Toyin, Karen A Mather, Nicola J Armstrong, et al.
BMC Geriatrics|September 15, 2017
A randomized controlled trial of physical activity with individual goal-setting and volunteer mentors to overcome sedentary lifestyle in older adults at risk of cognitive decline: the INDIGO trial protocolKay L Cox, Elizabeth V Cyarto, Christopher Etherton-Beer, et al.
Plos One|December 17, 2014
Genetics of microstructure of the corpus callosum in older adultsSri C Kanchibhotla, Karen A Mather, Anbupalam Thalamuthu, et al.
Journal of Clinical and Experimental Neuropsychology|January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
JAMA Neurology|May 29, 2013
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer diseaseVincent Doré, Victor L Villemagne, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|May 26, 2012
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal studyNicolas Villain, Gaël Chételat, Blandine Grassiot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Pageof 34